Telo Therapeutics Inc

Telo Therapeutics, Inc. develops oncology therapeutics within the biotechnology sector. The Company researches nuclear transport inhibitors, advances small molecule therapies to clinical trials, and develops targeted protein degraders for cancer therapy. Telo Therapeutics Inc serves patients in the United States with cancers refractory to existing medicines.